VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Wednesday, January 7, 2026

Stock Comparison

Auckland International Airport Limited vs Boston Scientific Corporation

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Auckland International Airport Limited

AIA · NZX

Market cap (USD)$14.3B
Gross margin (TTM)54.4%
Operating margin (TTM)55%
Net margin (TTM)23.3%
SectorIndustrials
IndustryAirlines, Airports & Air Services
CountryNZ
Data as of2025-12-28
Moat score
74/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Auckland International Airport Limited's moat claims, evidence, and risks.

View AIA analysis

Boston Scientific Corporation

BSX · New York Stock Exchange

Market cap (USD)$141.5B
Gross margin (TTM)65.1%
Operating margin (TTM)17.3%
Net margin (TTM)14.4%
SectorHealthcare
IndustryMedical - Devices
CountryUS
Data as of2026-01-04
Moat score
65/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Boston Scientific Corporation's moat claims, evidence, and risks.

View BSX analysis

Comparison highlights

  • Moat score gap: Auckland International Airport Limited leads (74 / 100 vs 65 / 100 for Boston Scientific Corporation).
  • Segment focus: Auckland International Airport Limited has 3 segments; Boston Scientific Corporation has 5 segments (49.8% in Cardiology).
  • Primary market structure: Monopoly vs Oligopoly. Pricing power: Moderate vs Moderate.
  • Moat breadth: Auckland International Airport Limited has 5 moat types across 3 domains; Boston Scientific Corporation has 6 across 3.

Primary market context

Auckland International Airport Limited

Aeronautical (regulated airport services)

Market

Aeronautical airport services at Auckland Airport (airfield landing/parking, passenger terminal and related charges)

Geography

New Zealand (Auckland catchment)

Customer

Airlines and aviation operators (direct customers); passengers indirectly

Role

Airport infrastructure operator

Boston Scientific Corporation

Cardiology

Market

Cardiology devices (interventional cardiology, structural heart, electrophysiology, cardiac rhythm management and remote monitoring)

Geography

Global

Customer

Hospitals/cath labs/EP labs and specialty clinics (cardiologists, electrophysiologists)

Role

Medical device OEM / implantables + procedure devices + service-enabled monitoring

Revenue share

49.8%

Side-by-side metrics

Auckland International Airport Limited
Boston Scientific Corporation
Ticker / Exchange
AIA - NZX
BSX - New York Stock Exchange
Market cap (USD)
$14.3B
$141.5B
Gross margin (TTM)
54.4%
65.1%
Operating margin (TTM)
55%
17.3%
Net margin (TTM)
23.3%
14.4%
Sector
Industrials
Healthcare
Industry
Airlines, Airports & Air Services
Medical - Devices
HQ country
NZ
US
Primary segment
Aeronautical (regulated airport services)
Cardiology
Market structure
Monopoly
Oligopoly
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
74 / 100
65 / 100
Moat domains
Legal, Supply, Demand
Demand, Legal, Supply
Last update
2025-12-28
2026-01-04

Moat coverage

Shared moat types

Distribution Control

Auckland International Airport Limited strengths

Permits Rights Of WayCapacity MoatLong Term ContractsGeographic Natural

Boston Scientific Corporation strengths

Installed Base ConsumablesProcurement InertiaTraining Org Change CostsRegulated Standards PipeReputation Reviews

Segment mix

Auckland International Airport Limited segments

Full profile >

Aeronautical (regulated airport services)

Monopoly

n/a

Retail concessions and car parking

Quasi-Monopoly

n/a

Commercial property and precinct development

Competitive

n/a

Boston Scientific Corporation segments

Full profile >

Endoscopy

Oligopoly

16%

Urology

Competitive

13.1%

Neuromodulation

Oligopoly

6.6%

Cardiology

Oligopoly

49.8%

Peripheral Interventions

Competitive

14.4%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.